Encompass Health to present at UBS Virtual Global Healthcare Conference
Get Alerts EHC Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +7.5%
Join SI Premium – FREE
BIRMINGHAM, Ala., April 30, 2020 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the UBS Virtual Global Healthcare Conference being held May 18‑20, 2020.
Encompass Health President and Chief Executive Officer Mark Tarr and Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat at 10 a.m. ET on Tuesday, May 19, 2020. The presentation will be webcast live and will be available at http://investor.encompasshealth.com by clicking on an available link.
About Encompass Health As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 134 hospitals, 245 home health locations, and 83 hospice locations in 37 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter and Facebook.
Media Contact Hillary Carnel, 205 970-5912 [email protected]
Investor Relations ContactCrissy Carlisle, 205 970-5860 [email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/encompass-health-to-present-at-ubs-virtual-global-healthcare-conference-301050004.html
SOURCE Encompass Health Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoNetrix Named a Top Small Business for Leadership and Career Growth by Comparably
- Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.
- Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
UBS, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share